文献速递白血病

吸烟状态对强化治疗急性髓系白血病预后的影响:丹麦全国队列研究

The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study.
PubMed 文献 · Br J Haematol · 2020-04-21

该研究基于丹麦国家白血病登记处数据,纳入2000至2012年诊断的18-75岁接受强化化疗的AML患者1040例,评估吸烟状态对预后的影响。

要点

  • 吸烟状态可作为AML患者临床决策中的患者相关预后因素。

核心结论

  • 在强化治疗的AML患者中,吸烟状态与较差的总生存期相关。

研究设计与样本

  • 基于丹麦国家白血病登记处的全国性队列研究,纳入2000年1月1日至2012年12月31日诊断的18-75岁AML患者,共1040例,中位年龄59岁。

临床怎么用

  • 在AML患者的预后评估和临床决策中,应考虑吸烟状态这一患者相关因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With rising life expectancy, the importance of patient-related prognostic factors and how to integrate such data into clinical decision-making becomes increasingly important. The aim of this study was to evaluate the prognostic impact of smoking status in patients with acute myeloid leukaemia (AML) treated with intensive chemotherapy. We conducted a nationwide cohort study based on data obtained from the Danish National Leukaemia Registry (DNLR). The study comprised Danish patients aged 18-75 years, diagnosed with AML between 1 January 2000 and 31 December 2012. Medical records were reviewed and data on smoking status were collected. A total of 1040 patients (median age 59 years) were included, and 602 patients (58·9%) were categorised as ever-smokers and the remaining as never-smokers. Kaplan-Meier survival estimates revealed that ever-smokers had a significant shorter median overall survival (OS) at 17·2 months [95% CI (14·9;19·1)] compared to never-smokers at 24·5 months (95% CI [19·2;30·7]). Multivariate analysis revealed smoking status as a significant prognostic factor for inferior OS with a hazard ratio (HR) of 1·22 [95% CI (1·04;1·44)]. In conclusion, smoking status was found to be associated with inferior OS in intensively treated AML patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kristensen D, Nielsen LB, Roug AS, et al. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study. Br J Haematol. 2020. PMID: 32316076. doi:10.1111/bjh.16667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。